SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-17-012663
Filing Date
2017-11-09
Accepted
2017-11-09 13:58:13
Documents
50
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm 10-Q/A 366192
2 ex31-1.htm EX-31.1 16110
3 ex32-1.htm EX-32.1 7738
4 GRAPHIC image_001.jpg GRAPHIC 8812
  Complete submission text file 0001493152-17-012663.txt   2745166

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE endv-20170930.xml EX-101.INS 417147
6 XBRL SCHEMA FILE endv-20170930.xsd EX-101.SCH 38550
7 XBRL CALCULATION FILE endv-20170930_cal.xml EX-101.CAL 39028
8 XBRL DEFINITION FILE endv-20170930_def.xml EX-101.DEF 160655
9 XBRL LABEL FILE endv-20170930_lab.xml EX-101.LAB 288394
10 XBRL PRESENTATION FILE endv-20170930_pre.xml EX-101.PRE 226513
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-55453 | Film No.: 171190048
SIC: 2834 Pharmaceutical Preparations